Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 23, Issue 4, 2017, Pages 670-676

  Green, Nancy S ^a   Bhatia, Monica ^a   Griffith, Erica Y ^a   Qureshi, Mahvish ^a   Briamonte, Courtney ^a   Savone, Mirko ^a   Sands, Stephen ^a   Lee, Margaret T ^a   Lignelli, Angela ^a   Brickman, Adam M ^a  

^a Department of Medicine   (United States)

Author keywords

Hematopoietic cell transplantation; Magnetic resonance imaging brain; Quality of life; Sickle cell disease; White matter hyperintensity

Indexed keywords

ALEMTUZUMAB; BIOLOGICAL MARKER; BUSULFAN; FLUDARABINE; MELPHALAN; MEPREDNISONE; METHOTREXATE; MYCOPHENOLATE MOFETIL; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BRAIN; BRAIN ANGIOGRAPHY; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN SIZE; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HUMAN; LONGITUDINAL STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MYELOABLATIVE CONDITIONING; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SELF REPORT; SICKLE CELL ANEMIA; WHITE MATTER HYPERINTENSITY; DIAGNOSTIC IMAGING; MICROCIRCULATION; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; VASCULARIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BRAIN; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85012924416     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2017.01.007     Document Type: Article

References (37)

1. 1 Pegelow, C.H., Macklin, E.A., Moser, F.G., et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 99 (2002), 3014–3018.
2. 2 DeBaun, M.R., Kirkham, F.J., Central nervous system complications and management in sickle cell disease. Blood 127 (2016), 829–838.
3. 3 Kwiatkowski, J.L., Zimmerman, R.A., Pollock, A.N., et al. Silent infarcts in young children with sickle cell disease. Br J Haematol 146 (2009), 300–305.
4. 4 Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91 (1998), 288–294.
5. 5 DeBaun, M.R., Armstrong, F.D., McKinstry, R.C., Ware, R.E., Vichinsky, E., Kirkham, F.J., Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood 119 (2012), 4587–4596.
6. 6 Wang, W.C., Pavlakis, S.G., Helton, K.J., et al. MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer 51 (2008), 643–646.
7. 7 Quinn, C.T., McKinstry, R.C., Dowling, M.M., et al. Acute silent cerebral ischemic events in children with sickle cell anemia. JAMA Neurol 70 (2013), 58–65.
8. 8 van der Land, V., Hijmans, C.T., de Ruiter, M., et al. Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell disease. Br J Haematol 168 (2015), 553–556.
9. 9 Schatz, J., White, D.A., Moinuddin, A., Armstrong, M., DeBaun, M.R., Lesion burden and cognitive morbidity in children with sickle cell disease. J Child Neurol 17 (2002), 891–895.
10. 10 Walters, M.C., Patience, M., Leisenring, W., et al. Bone marrow transplantation for sickle cell disease. NEJM 335 (1996), 369–376.
11. 11 Angelucci, E., Matthes-Martin, S., Baronciani, D., et al. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica 99 (2014), 811–820.
12. 12 Bernaudin, F., Socie, G., Kuentz, M., et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 110 (2007), 2749–2756.
13. 13 Bhatia, M., Walters, M.C., Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 41 (2008), 109–117.
14. 14 Walters, M.C., Storb, R., Patience, M., et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 95 (2000), 1918–1924.
15. 15 Walters, M.C., Sullivan, K.M., Bernaudin, F., et al. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 85 (1995), 879–884.
16. 16 Bodas, P., Rotz, S., Cerebral vascular abnormalities in pediatric patients with sickle cell disease after hematopoietic cell transplant. J Pediatr Hematol Oncol 36 (2014), 190–193.
17. 17 Woodard, P., Helton, K.J., Khan, R.B., et al. Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol 129 (2005), 550–552.
18. 18 Helton, K.J., Adams, R.J., Kesler, K.L., et al. Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Blood 124 (2014), 891–898.
19. 19 Schilling, S., DeStefano, A.L., Sachdev, P.S., et al. APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis. Neurology 81 (2013), 292–300.
20. 20 Debette, S., Markus, H.S., The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ, 341, 2010, c3666.
21. 21 Walters, M.C., Hardy, K., Edwards, S., et al. Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant 16 (2010), 263–272.
22. 22 Varni, J.W., Burwinkle, T.M., Seid, M., Skarr, D., The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 3 (2003), 329–341.
23. 23 Bhatia, M., Jin, Z., Baker, C., et al. Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplant 49 (2014), 913–920.
24. 24 Brickman, A.M., Sneed, J.R., Provenzano, F.A., et al. Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res 193 (2011), 101–106.
25. 25 Brickman, A.M., Zahra, A., Muraskin, J., et al. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res 172 (2009), 117–120.
26. 26 Varni, J.W., Seid, M., Kurtin, P.S., PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 39 (2001), 800–812.
27. 27 Bhatia, M., Kolva, E., Cimini, L., et al. Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease. Biol Blood Marrow Transplant 21 (2015), 666–672.
28. 28 Liem, R.I., Liu, J., Gordon, M.O., et al. Reproducibility of detecting silent cerebral infarcts in pediatric sickle cell anemia. J Child Neurol 29 (2014), 1685–1691.
29. 29 Kim, B.J., Lee, S.H., Prognostic impact of cerebral small vessel disease on stroke outcome. J Stroke 17 (2015), 101–110.
30. 30 Baldeweg, T., Hogan, A.M., Saunders, D.E., et al. Detecting white matter injury in sickle cell disease using voxel-based morphometry. Ann Neurol 59 (2006), 662–672.
31. 31 Hulbert, M.L., McKinstry, R.C., Lacey, J.L., et al. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood 117 (2011), 772–779.
32. 32 Panepinto, J.A., Torres, S., Bendo, C.B., et al. PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity. Pediatr Blood Cancer 61 (2014), 171–177.
33. 33 Trullemans, F., Grignard, F., Van Camp, B., Schots, R., Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol 67 (2001), 94–99.
34. 34 Kawadler, J.M., Kirkham, F.J., Clayden, J.D., et al. White matter damage relates to oxygen saturation in children with sickle cell anemia without silent cerebral infarcts. Stroke 46 (2015), 1793–1799.
35. 35 Sun, B., Brown, R.C., Hayes, L., et al. White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging. AJNR Am J Neuroradiol 33 (2012), 2043–2049.
36. 36 Helton, K.J., Glass, J.O., Reddick, W.E., et al. Comparing segmented ASL perfusion of vascular territories using manual versus semiautomated techniques in children with sickle cell anemia. J Magn Reson Imaging 41 (2015), 439–446.
37. 37 Bernaudin, F., Verlhac, S., Arnaud, C., et al. Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities. Blood 127 (2016), 1814–1822.